More about

Tuberculosis

News
October 20, 2023
3 min read
Save

In Africa, PEPFAR countries test more for COVID-19, showing impact of investment

In Africa, PEPFAR countries test more for COVID-19, showing impact of investment

BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.

News
September 29, 2023
1 min read
Save

What other ID dogma should be reevaluated?

What other ID dogma should be reevaluated?

As experts raise awareness of the evidence supporting shorter antibiotic therapy for some conditions and the benefits of oral vs. IV-only therapy for others, we wanted to know: What is another ID dogma that should be reevaluated?

News
August 28, 2023
3 min read
Save

Asthma, allergic rhinitis associated with risks for mycobacterial disease

Asthma, allergic rhinitis associated with risks for mycobacterial disease

Patients with asthma or allergic rhinitis had greater risk for mycobacterial disease than patients who did not have these allergic diseases, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
June 29, 2023
4 min read
Save

Childhood TB may be linked to wheezing, poor lung function, low weight, height

Childhood TB may be linked to wheezing, poor lung function, low weight, height

Early-life TB was related to future wheezing, weak lung function and low measures of weight and height at 5 years old, according to study results published in American Journal of Respiratory and Critical Care Medicine.

News
June 28, 2023
2 min read
Save

TB vaccine candidate gets up to $550 million in funding for phase 3 trial

TB vaccine candidate gets up to $550 million in funding for phase 3 trial

Wellcome and the Bill & Melinda Gates Foundation announced Wednesday that they will provide up to $550 million in funding for a phase 3 trial of a tuberculosis vaccine candidate.

News
June 10, 2023
2 min read
Save

BPaL a ‘game-changer’ for treatment of drug-resistant tuberculosis

BPaL a ‘game-changer’ for treatment of drug-resistant tuberculosis

BPaL shortens treatment times significantly and shows few adverse effects in patients with drug-resistant tuberculosis , according to data published in Clinical Infectious Diseases.

News
June 02, 2023
1 min read
Save

Jeffrey R. Starke, MD

Jeffrey R. Starke, MD

Jeffrey R. Starke, MD, is a professor of pediatrics at Baylor College of Medicine.

News
May 08, 2023
5 min read
Save

Woman presents with amelanotic deep mass in left eye

Woman presents with amelanotic deep mass in left eye

A 79-year-old woman presented for a routine follow-up appointment as a glaucoma suspect in February 2022 at Lahey Medical Center. She reported long-standing difficulty with distance vision in both eyes but had no acute visual complaints.

News
May 03, 2023
3 min read
Save

USPSTF finalizes recommendation on latent tuberculosis screening

USPSTF finalizes recommendation on latent tuberculosis screening

Adults who have an increased risk for tuberculosis should be screened for latent TB infection, according to a final recommendation statement from the U.S. Preventive Services Task Force.

News
April 13, 2023
3 min read
Save

Higher risk for tuberculosis diagnosis with wildfire smoke exposure

Higher risk for tuberculosis diagnosis with wildfire smoke exposure

Heightened odds for a tuberculosis diagnosis were related to exposure to ambient air pollution that contained wildfire smoke, according to results published in American Journal of Respiratory and Critical Care Medicine.

View more